CA1277901C - Moyens de traiter les infections a herpesvirus - Google Patents

Moyens de traiter les infections a herpesvirus

Info

Publication number
CA1277901C
CA1277901C CA 530250 CA530250A CA1277901C CA 1277901 C CA1277901 C CA 1277901C CA 530250 CA530250 CA 530250 CA 530250 A CA530250 A CA 530250A CA 1277901 C CA1277901 C CA 1277901C
Authority
CA
Canada
Prior art keywords
val
peptide
pharmaceutical composition
ala
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA 530250
Other languages
English (en)
Inventor
Eric A. Cohen
Pierrette Gaudreau
Jacques Michaud
Paul Brazeau
Yves Langelier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 530250 priority Critical patent/CA1277901C/fr
Priority to US07/046,707 priority patent/US4795740A/en
Priority to NZ220365A priority patent/NZ220365A/xx
Priority to AU73210/87A priority patent/AU602334B2/en
Priority to ES87107327T priority patent/ES2054630T3/es
Priority to DE8787107327T priority patent/DE3785388T2/de
Priority to AT87107327T priority patent/ATE88189T1/de
Priority to EP87107327A priority patent/EP0246630B1/fr
Priority to US07/244,879 priority patent/US5066783A/en
Application granted granted Critical
Publication of CA1277901C publication Critical patent/CA1277901C/fr
Expired legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 530250 1986-05-20 1987-02-20 Moyens de traiter les infections a herpesvirus Expired CA1277901C (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CA 530250 CA1277901C (fr) 1987-02-20 1987-02-20 Moyens de traiter les infections a herpesvirus
US07/046,707 US4795740A (en) 1986-05-20 1987-05-07 Antiviral peptides and means for treating herpes infections
AU73210/87A AU602334B2 (en) 1986-05-20 1987-05-19 Antiviral peptides and means for treating herpes infections
NZ220365A NZ220365A (en) 1986-05-20 1987-05-19 Antiviral peptides and pharmaceutical compositions
ES87107327T ES2054630T3 (es) 1986-05-20 1987-05-20 Peptidos antivirales y medios para tratar infecciones de herpes.
DE8787107327T DE3785388T2 (de) 1986-05-20 1987-05-20 Antivirale peptide und mittel zur behandlung von herpes.
AT87107327T ATE88189T1 (de) 1986-05-20 1987-05-20 Antivirale peptide und mittel zur behandlung von herpes.
EP87107327A EP0246630B1 (fr) 1986-05-20 1987-05-20 Peptides antiviraux et moyens pour le traitement de l'herpès
US07/244,879 US5066783A (en) 1986-05-20 1988-09-15 Antiviral peptides and means for treating herpes infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 530250 CA1277901C (fr) 1987-02-20 1987-02-20 Moyens de traiter les infections a herpesvirus

Publications (1)

Publication Number Publication Date
CA1277901C true CA1277901C (fr) 1990-12-18

Family

ID=4135019

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 530250 Expired CA1277901C (fr) 1986-05-20 1987-02-20 Moyens de traiter les infections a herpesvirus

Country Status (1)

Country Link
CA (1) CA1277901C (fr)

Similar Documents

Publication Publication Date Title
US4795740A (en) Antiviral peptides and means for treating herpes infections
US5484771A (en) Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus
EP0573538B1 (fr) Peptides a usage therapeutique
US5633230A (en) Treatment of cytomegalovirus infection
AU648854B2 (en) Synergistic combination for treating herpes infections
US5552384A (en) Antiherpes compositions and method of use
CA1277901C (fr) Moyens de traiter les infections a herpesvirus
US5700780A (en) Antiviral peptide derivatives having a 2-oxoalkyl amino acid side chain
US5066783A (en) Antiviral peptides and means for treating herpes infections
CA2152373C (fr) Traitement de l'infection provoquee par le cytomegalovirus
AU683450B2 (en) Inhibitors of herpes viral ribonucleotide reductase
CA1340684C (fr) Pentapeptides antiherpetiques
US5002932A (en) Antiviral pharmaceutical compositions and method of treating herpes
Freeman et al. Recombinant human interferon-αA treatment of an experimental cutaneous herpes simplex virus type 1 infection of guinea pigs
JPH0641189A (ja) ウレイドｎ−末端を有するペプチド誘導体抗ヘルペス剤
JPS62289597A (ja) 抗ウイルス性ペプチド及びヘルペス感染治療法
CA2019005C (fr) Derives pentapeptidiques anti-herpes ayant une chaine laterale d'acide aspartique substitue par un groupement cycloalkyl

Legal Events

Date Code Title Description
MKLA Lapsed